Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.35 |
| ▸ | CDC25B | P30305 | 4/20 | 0.35 |
| ▸ | ACP1 | P24666 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4129548 | 0.83 | PTPN1 (0.32) | PTPN1CDC25BACP1CYP1A2 | |
| SCHEMBL2284084 | 0.67 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL11686043 | 0.58 | TYMP (0.33) | PKM | |
| SCHEMBL15201842 | 0.57 | TSHR (0.44) | ALDH1A1 | |
| SCHEMBL15202306 | 0.57 | TSHR (0.44) | ALDH1A1 | |
| SCHEMBL15201249 | 0.57 | TSHR (0.44) | ALDH1A1 | |
| SCHEMBL15201443 | 0.57 | TSHR (0.44) | ALDH1A1 | |
| SCHEMBL15821046 | 0.57 | ALDH1A1 (0.45) | CYP1A2ALDH1A1L3MBTL1PKM | |
| SCHEMBL2580220 | 0.57 | ALDH1A1 (0.67) | CYP1A2ALDH1A1L3MBTL1PKM | |
| SCHEMBL572791 | 0.55 | ALDH1A1 (0.64) | CYP1A2ALDH1A1L3MBTL1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100272783-A1 | Methods of Treating Infections of the Nail | NOVABAY PHARMACEUTICALS, INC. | 2010-10-28 | — | — | US | claimed |
| WO-2010124237-A1 | METHODS OF TREATING INFECTIONS OF THE NAIL | NOVABAY PHARMACEUTICALS INC. (US) | 2010-10-28 | — | — | WO | claimed |
| US-20090239907-A1 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | HALOSOURCE, INC. (US) | 2009-09-24 | — | — | US | claimed |
| EP-1996187-A2 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | Halosource, Inc. (US) | 2008-12-03 | — | — | EP | claimed |
| WO-2008115225-A2 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | HALOSOURCE, INC. (US) | 2008-09-25 | — | — | WO | claimed |
| JP-3072774-B2 | — | — | 2000-08-07 | — | — | JP | claimed |
| EP-0513239-B1 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | UNIV AUBURN (US) | 1998-04-08 | — | — | EP | claimed |
| EP-0513239-A4 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | — | 1993-03-10 | — | — | EP | claimed |
| EP-0513239-A1 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | AUBURN UNIVERSITY (US) | 1992-11-19 | — | — | EP | claimed |
| US-5126057-A | Stabilizers against solar radiation | AUBURN RESEARCH FOUNDATION (US) | 1992-06-30 | — | — | US | claimed |
| US-5057612-A | Stable, noncorrosive bicoide, disinfectant | AUBURN RESEARCH FOUNDATION (US) | 1991-10-15 | — | — | US | claimed |
| WO-1991010623-A1 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | AUBURN UNIVERSITY (US) | 1991-07-25 | — | — | WO | claimed |
| US-8563587-B2 | Methods and compositions for treating fish diseases | HALOSOURCE, INC. (US) | 2013-10-22 | — | — | US | disclosed |
| US-20110190392-A1 | Polysaccharide Based Antimicrobial Formulations | NOVABAY PHARMACEUTICALS, INC. | 2011-08-04 | — | — | US | disclosed |
| WO-2010124237-A1 | METHODS OF TREATING INFECTIONS OF THE NAIL | NOVABAY PHARMACEUTICALS INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| US-20100272783-A1 | Methods of Treating Infections of the Nail | NOVABAY PHARMACEUTICALS, INC. | 2010-10-28 | — | — | US | disclosed |
| EP-0513239-A1 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | AUBURN UNIVERSITY (US) | 1992-11-19 | — | — | EP | disclosed |
| US-5126057-A | Stabilizers against solar radiation | AUBURN RESEARCH FOUNDATION (US) | 1992-06-30 | — | — | US | disclosed |
| US-5057612-A | Stable, noncorrosive bicoide, disinfectant | AUBURN RESEARCH FOUNDATION (US) | 1991-10-15 | — | — | US | disclosed |
| WO-1991010623-A1 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | AUBURN UNIVERSITY (US) | 1991-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100272783-A1 | Methods of Treating Infections of the Nail | POLR1C, TYR, NACA | PTPN1 1939/4885CDC25B 2017/4885ACP1 3110/4885 |
| US-20090239907-A1 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | AQP3, AQP1, NISCH | PTPN1 3922/4885CDC25B 3958/4885ACP1 4704/4885 |
| US-20110190392-A1 | Polysaccharide Based Antimicrobial Formulations | FUT6, FUT5, OGT | PTPN1 3560/4885CDC25B 2646/4885ACP1 3659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.